Permanent unilateral hearing loss after radiotherapy for parotid gland tumors

Autor: John T. M. Plukker, Remco de Bree, C. René Leemans, Cas Smits, Fred R. Burlage, Lisa van der Putten, Johannes A. Langendijk
Přispěvatelé: Faculteit Medische Wetenschappen/UMCG, Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS), Otolaryngology / Head & Neck Surgery, Radiation Oncology
Jazyk: angličtina
Rok vydání: 2006
Předmět:
Zdroj: Head and Neck: Journal of the Sciences and Specialties of the Head and Neck, 28(10), 902-908. Wiley
Head and Neck, 28(10), 902-908. Wiley Subscription Services, Inc., A Wiley Company Hoboken
van der Putten, L, de Bree, R, Plukker, J T, Langendijk, J A, Smits, C, Burlage, F R & Leemans, C R 2006, ' Permanent unilateral hearing loss after radiotherapy for parotid gland tumors ', Head and Neck, vol. 28, no. 10, pp. 902-908 .
ISSN: 1043-3074
Popis: Background. The purpose of this retrospective study was to determine the long-term effects of radiotherapy on hearing function in patients who underwent parotidectomy and postoperative radiotherapy for unilateral tumors of the parotid gland.Methods, An extensive set of tests was used to measure hearing loss. The mean dose on middle ear, cochlea, and Eustachian tube was estimated with a CT-planning system.Results. A hearing loss of >= 15 dB in 3 frequencies was found in 32% of the 52 patients included in the study. Patients with an asymmetrical hearing loss received a higher mean dose on the hearing structures (p Conclusions. Radiation-induced hearing loss is a common complication. A mean dose of > 50 Gy on the cochlea should be avoided. (c) 2006 Wiley Periodicals, Inc.
Databáze: OpenAIRE